July 22, 2022 Cost Estimate As ordered reported by the House Committee on the Judiciary on September 29, 2021 View Document172.07 KB Summary H.R. 2873 would establish a statutory framework for the Federal Trade Commission to undertake litigation against manufacturers that engage in “product hopping.” Legislative Information Available From Congress.gov Related Publications Estimated Budgetary Effects of S. 1435, the Affordable Prescriptions for Patients Act of 2021June 6, 2022
H.R. 2873 would establish a statutory framework for the Federal Trade Commission to undertake litigation against manufacturers that engage in “product hopping.”
